Free Trial
NYSE:COR

Cencora Q2 2025 Earnings Report

Cencora logo
$291.12 -0.85 (-0.29%)
Closing price 03:59 PM Eastern
Extended Trading
$292.02 +0.90 (+0.31%)
As of 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cencora EPS Results

Actual EPS
N/A
Consensus EPS
$4.07
Beat/Miss
N/A
One Year Ago EPS
N/A

Cencora Revenue Results

Actual Revenue
N/A
Expected Revenue
$75.41 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cencora Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Wednesday, May 7, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Cencora Earnings Headlines

Cencora Earnings: What To Look For From COR
Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…
Cencora (COR) Surged on Strong Returns
See More Cencora Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cencora? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cencora and other key companies, straight to your email.

About Cencora

Cencora (NYSE:COR) sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

View Cencora Profile

More Earnings Resources from MarketBeat